Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.
2.
3.
4.

Frequency analysis of autoreactive T-helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by enzyme-linked immunospot assay.

Eming R, Büdinger L, Riechers R, Christensen O, Bohlen H, Kalish R, Hertl M.

Br J Dermatol. 2000 Dec;143(6):1279-82.

PMID:
11122034
5.

Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus.

Amagai M, Komai A, Hashimoto T, Shirakata Y, Hashimoto K, Yamada T, Kitajima Y, Ohya K, Iwanami H, Nishikawa T.

Br J Dermatol. 1999 Feb;140(2):351-7.

PMID:
10233237
6.

Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active disease.

Rizzo C, Fotino M, Zhang Y, Chow S, Spizuoco A, Sinha AA.

Clin Exp Dermatol. 2005 Sep;30(5):535-40.

PMID:
16045688
7.

Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.

Eming R, Hennerici T, Bäcklund J, Feliciani C, Visconti KC, Willenborg S, Wohde J, Holmdahl R, Sønderstrup G, Hertl M.

J Immunol. 2014 Nov 1;193(9):4391-9. doi: 10.4049/jimmunol.1401081. Epub 2014 Sep 24.

8.

IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris.

Spaeth S, Riechers R, Borradori L, Zillikens D, Büdinger L, Hertl M.

Br J Dermatol. 2001 Jun;144(6):1183-8.

PMID:
11422039
10.

Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.

Ishii K, Amagai M, Hall RP, Hashimoto T, Takayanagi A, Gamou S, Shimizu N, Nishikawa T.

J Immunol. 1997 Aug 15;159(4):2010-7.

PMID:
9257868
11.

T lymphocytes from a subset of patients with pemphigus vulgaris respond to both desmoglein-3 and desmoglein-1.

Lin MS, Swartz SJ, Lopez A, Ding X, Fairley JA, Diaz LA.

J Invest Dermatol. 1997 Dec;109(6):734-7.

12.

T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals.

Veldman CM, Gebhard KL, Uter W, Wassmuth R, Grötzinger J, Schultz E, Hertl M.

J Immunol. 2004 Mar 15;172(6):3883-92.

13.

HLA-DRB1 polymorphisms and autoimmune responses to desmogleins in Japanese patients with pemphigus.

Miyagawa S, Amagai M, Niizeki H, Yamashina Y, Kaneshige T, Nishikawa T, Shirai T, Inoko H.

Tissue Antigens. 1999 Oct;54(4):333-40.

PMID:
10551416
14.

Ex vivo analysis of desmoglein 1-responsive T-helper (Th) 1 and Th2 cells in patients with pemphigus foliaceus and healthy individuals.

Gebhard KL, Veldman CM, Wassmuth R, Schultz E, Schuler G, Hertl M.

Exp Dermatol. 2005 Aug;14(8):586-92.

PMID:
16026580
15.

Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus.

Nguyen VT, Ndoye A, Bassler KD, Shultz LD, Shields MC, Ruben BS, Webber RJ, Pittelkow MR, Lynch PJ, Grando SA.

Arch Dermatol. 2001 Feb;137(2):193-206.

PMID:
11176692
16.
17.

Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3.

Nagel A, Lang A, Engel D, Podstawa E, Hunzelmann N, de Pita O, Borradori L, Uter W, Hertl M.

Clin Immunol. 2010 Mar;134(3):320-30. doi: 10.1016/j.clim.2009.11.006. Epub 2009 Dec 16.

PMID:
20015693
18.

Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies.

Calkins CC, Setzer SV, Jennings JM, Summers S, Tsunoda K, Amagai M, Kowalczyk AP.

J Biol Chem. 2006 Mar 17;281(11):7623-34. Epub 2005 Dec 23.

19.

Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus.

Ohyama M, Amagai M, Hashimoto T, Nousari HC, Anhalt GJ, Nishikawa T.

J Am Acad Dermatol. 2001 Apr;44(4):593-8.

PMID:
11260531
20.

Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool.

Lenz P, Amagai M, Volc-Platzer B, Stingl G, Kirnbauer R.

Arch Dermatol. 1999 Feb;135(2):143-8.

PMID:
10052398

Supplemental Content

Support Center